{"id":"https://openalex.org/W36685300","doi":null,"title":"Recent advances in low- and intermediate-1-risk myelodysplastic syndrome: developing a consensus for optimal therapy.","display_name":"Recent advances in low- and intermediate-1-risk myelodysplastic syndrome: developing a consensus for optimal therapy.","publication_year":2008,"publication_date":"2008-12-01","ids":{"openalex":"https://openalex.org/W36685300","mag":"36685300","pmid":"https://pubmed.ncbi.nlm.nih.gov/19385003"},"language":"en","primary_location":{"id":"pmid:19385003","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19385003","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical advances in hematology & oncology : H&O","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071023119","display_name":"Richard Maury Stone","orcid":"https://orcid.org/0000-0002-7526-2633","observed_orcids":["https://orcid.org/0000-0002-7526-2633"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Stone","raw_affiliation_strings":["Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055740968","display_name":"Mikkael Aaron Sekeres","orcid":"https://orcid.org/0000-0003-2009-6524","observed_orcids":["https://orcid.org/0000-0003-2009-6524"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mikkael Sekeres","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guillermo Garcia-Manero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5025294989","display_name":"Roger M. Lyons","orcid":"https://orcid.org/0000-0001-6508-8080","observed_orcids":["https://orcid.org/0000-0001-6508-8080"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roger M Lyons","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7012,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.84187957,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"12","first_page":"1","last_page":"15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9950000047683716},{"id":"https://openalex.org/keywords/lower-risk-mds","display_name":"low-risk MDS","score":0.8349999785423279},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.949999988079071},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":1.0},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":1.0},{"id":"https://openalex.org/keywords/aml-transformation","display_name":"AML transformation","score":0.7160000205039978},{"id":"https://openalex.org/keywords/bone-marrow-failure","display_name":"bone marrow failure","score":0.7049999833106995},{"id":"https://openalex.org/keywords/cytopenia","display_name":"cytopenia","score":0.7229999899864197},{"id":"https://openalex.org/keywords/iron-overload","display_name":"iron overload","score":0.7279999852180481},{"id":"https://openalex.org/keywords/chronic-transfusion-therapy","display_name":"chronic transfusion","score":0.8240000009536743},{"id":"https://openalex.org/keywords/treatment-consensus","display_name":"treatment consensus","score":0.44200000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9592427015304565},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.8293248414993286},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.7306662797927856},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.7120904922485352},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.5696927309036255},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5639915466308594},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.5575891137123108},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5145458579063416},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.5042442083358765},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4945835769176483},{"id":"https://openalex.org/C2780525284","wikidata":"https://www.wikidata.org/wiki/Q7882181","display_name":"Bone marrow failure","level":4,"score":0.43634453415870667},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4282483458518982},{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.4196379780769348},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.36659106612205505},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3527895212173462},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.2788006663322449},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.21032199263572693},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.18389227986335754},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.16101789474487305},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077209","descriptor_name":"Decitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077269","descriptor_name":"Lenalidomide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001803","descriptor_name":"Blood Transfusion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D032921","descriptor_name":"Consensus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:19385003","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19385003","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical advances in hematology & oncology : H&O","raw_type":"Journal Article"},{"id":"mag:36685300","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19385003","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W187238933","https://openalex.org/W1519963426","https://openalex.org/W1541533982","https://openalex.org/W1973532909","https://openalex.org/W1979934252","https://openalex.org/W1980514257","https://openalex.org/W1983392832","https://openalex.org/W1984706919","https://openalex.org/W1986544757","https://openalex.org/W1988907854","https://openalex.org/W2000252768","https://openalex.org/W2004089260","https://openalex.org/W2006456576","https://openalex.org/W2017394727","https://openalex.org/W2017514019","https://openalex.org/W2018158113","https://openalex.org/W2019163316","https://openalex.org/W2020828641","https://openalex.org/W2021333892","https://openalex.org/W2025706850","https://openalex.org/W2029595590","https://openalex.org/W2035714642","https://openalex.org/W2036608644","https://openalex.org/W2072122397","https://openalex.org/W2073291761","https://openalex.org/W2082802216","https://openalex.org/W2099071696","https://openalex.org/W2106584820","https://openalex.org/W2108645403","https://openalex.org/W2110949925","https://openalex.org/W2114492363","https://openalex.org/W2117291755","https://openalex.org/W2119920607","https://openalex.org/W2125965467","https://openalex.org/W2129366901","https://openalex.org/W2129510594","https://openalex.org/W2137217791","https://openalex.org/W2148968593","https://openalex.org/W2153053980","https://openalex.org/W2153901235","https://openalex.org/W2154211587","https://openalex.org/W2155296700","https://openalex.org/W2159156084","https://openalex.org/W2163583950","https://openalex.org/W2204433245","https://openalex.org/W2242100625","https://openalex.org/W2555514872","https://openalex.org/W2575735043","https://openalex.org/W2588972323","https://openalex.org/W2590925255"],"related_works":["https://openalex.org/W278144882","https://openalex.org/W2345547076","https://openalex.org/W2145057843","https://openalex.org/W2065484973","https://openalex.org/W2395739978","https://openalex.org/W2564740428","https://openalex.org/W2502059843","https://openalex.org/W1896600276","https://openalex.org/W4300690320","https://openalex.org/W1967486797"],"abstract_inverted_index":{"Myelodysplastic":[0],"syndrome":[1],"(MDS)":[2],"is":[3,129],"relatively":[4],"common,":[5],"with":[6,158,191],"an":[7,38],"incidence":[8],"estimated":[9],"as":[10,12,72,137,139,197,199],"high":[11],"50":[13],"cases":[14],"per":[15,18],"100,000":[16],"people":[17],"year.":[19],"This":[20,181],"cancer":[21],"mainly":[22],"affects":[23],"older":[24],"(>or=60":[25],"years)":[26],"patients.":[27],"MDS":[28,76,95,207],"refers":[29],"to":[30,63,89,119,134,205],"a":[31],"collection":[32],"of":[33,43,66,100,125,156,162,169,189,193],"hematologic":[34],"malignancies":[35],"that":[36],"share":[37],"ineffective":[39],"production,":[40],"or":[41,47,74,149],"hematopoiesis,":[42],"normal":[44],"bone":[45,52,67,101],"marrow":[46,53,68,102],"myeloid":[48],"cells.":[49],"As":[50,94],"progressive":[51],"failure":[54],"occurs,":[55],"patients":[56,77,190],"generally":[57],"display":[58],"gradually":[59],"worsening":[60],"cytopenias":[61],"specific":[62],"the":[64,98,105,132,140,154,159,167,186,200],"type":[65],"cell":[69],"affected,":[70],"such":[71],"thrombocytopenia":[73],"neutropenia.":[75],"often":[78],"develop":[79],"disease-related":[80],"anemia":[81],"requiring":[82],"chronic":[83],"blood":[84],"transfusion;":[85],"this":[86],"can":[87],"lead":[88],"complications":[90],"including":[91],"iron":[92],"overload.":[93],"progresses":[96],"and":[97,121,165,179],"number":[99],"blasts":[103],"increases,":[104],"disease":[106],"transforms":[107],"into":[108],"acute":[109],"myelogenous":[110],"leukemia":[111],"(AML).":[112],"Several":[113,144],"classification":[114,202],"systems":[115,203],"have":[116,146],"been":[117,147],"developed":[118,148],"identify":[120],"differentiate":[122,206],"particular":[123],"types":[124],"MDS.":[126],"Proper":[127],"identification":[128],"essential,":[130],"allowing":[131],"oncologist":[133],"determine":[135],"prognosis,":[136],"well":[138,198],"optimal":[141,187],"therapeutic":[142,160],"strategy.":[143],"agents":[145,174],"are":[150,175],"under":[151],"investigation":[152],"for":[153,209],"treatment":[155],"MDS,":[157],"goal":[161],"increasing":[163],"survival":[164],"decreasing":[166],"rate":[168],"AML":[170],"transformation.":[171],"Currently,":[172],"3":[173],"FDA-approved:":[176],"azacitidine,":[177],"decitabine,":[178],"lenalidomide.":[180],"clinical":[182],"roundtable":[183],"will":[184],"discuss":[185],"management":[188],"each":[192],"these":[194],"approved":[195],"therapies,":[196],"various":[201],"used":[204],"subtypes":[208],"treatment.":[210]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}